CA2323604A1 - Interferon alpha plasmids and delivery systems, and methods of making and using the same - Google Patents
Interferon alpha plasmids and delivery systems, and methods of making and using the same Download PDFInfo
- Publication number
- CA2323604A1 CA2323604A1 CA002323604A CA2323604A CA2323604A1 CA 2323604 A1 CA2323604 A1 CA 2323604A1 CA 002323604 A CA002323604 A CA 002323604A CA 2323604 A CA2323604 A CA 2323604A CA 2323604 A1 CA2323604 A1 CA 2323604A1
- Authority
- CA
- Canada
- Prior art keywords
- plasmid
- sequence
- composition
- coding sequence
- interferon alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7865498P | 1998-03-19 | 1998-03-19 | |
US60/078,654 | 1998-03-19 | ||
PCT/US1999/005394 WO1999047678A2 (en) | 1998-03-19 | 1999-03-12 | Interferon alpha plasmids and delivery systems, and methods of making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2323604A1 true CA2323604A1 (en) | 1999-09-23 |
Family
ID=22145430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002323604A Abandoned CA2323604A1 (en) | 1998-03-19 | 1999-03-12 | Interferon alpha plasmids and delivery systems, and methods of making and using the same |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1064383A2 (de) |
JP (1) | JP2002506647A (de) |
AU (1) | AU3000399A (de) |
CA (1) | CA2323604A1 (de) |
WO (1) | WO1999047678A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030175897A1 (en) * | 2000-04-14 | 2003-09-18 | Thayer Edward C. | Human interferon, Zinf2 |
US8022270B2 (en) | 2000-07-31 | 2011-09-20 | Biolex Therapeutics, Inc. | Expression of biologically active polypeptides in duckweed |
US7632983B2 (en) | 2000-07-31 | 2009-12-15 | Biolex Therapeutics, Inc. | Expression of monoclonal antibodies in duckweed |
DK1305437T3 (da) | 2000-07-31 | 2010-12-13 | Biolex Therapeutics Inc | Ekspression af biologisk aktive polypeptider i andemad |
EP1195436A1 (de) * | 2000-10-04 | 2002-04-10 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Expressionsvektoren mit veränderter ColE1 Replikationsursprung zur Kontrolle der Plasmidkopienzahl |
US7468242B2 (en) | 2001-11-05 | 2008-12-23 | Medgenics, Inc. | Dermal micro organs, methods and apparatuses for producing and using the same |
US8501396B2 (en) | 2001-11-05 | 2013-08-06 | Medgenics Medical Israel Ltd. | Dermal micro-organs, methods and apparatuses for producing and using the same |
EP2377402A1 (de) | 2003-05-01 | 2011-10-19 | Medgenics, Inc. | Genetisch modifiziertes dermisches mikroorgan-ausdrückendes Interferon |
WO2007084364A2 (en) * | 2006-01-13 | 2007-07-26 | The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health | Improved il-12 for expression in mammalian cells |
JP2010504909A (ja) | 2006-09-14 | 2010-02-18 | メドジェニクス・メディカル・イスラエル・リミテッド | 長期持続性の医薬製剤 |
US8454948B2 (en) | 2006-09-14 | 2013-06-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
WO2009140206A1 (en) * | 2008-05-11 | 2009-11-19 | The Gov. Of The U. S. A., As Represented By The Secretary Of The Dept. Of Health And Human Services | Improved expression of il-12 family heterodimers |
AU2011268458B2 (en) | 2010-06-15 | 2014-06-12 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
KR102674807B1 (ko) | 2011-12-12 | 2024-06-13 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법 |
AU2018246292A1 (en) | 2017-03-31 | 2019-10-10 | Accanis Biotech F&E Gmbh & Co Kg | Prevention and treatment of non-melanoma skin cancer (NMSC) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641665A (en) * | 1994-11-28 | 1997-06-24 | Vical Incorporated | Plasmids suitable for IL-2 expression |
US6040295A (en) * | 1995-01-13 | 2000-03-21 | Genemedicine, Inc. | Formulated nucleic acid compositions and methods of administering the same for gene therapy |
WO1997000321A1 (en) * | 1995-06-14 | 1997-01-03 | Commonwealth Scientific And Industrial Research Organisation | Immune response modulators and uses therefor |
WO1997000085A1 (en) * | 1995-06-19 | 1997-01-03 | University Of Medicine & Dentistry Of New Jersey | Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins |
WO1997033998A1 (en) * | 1996-03-14 | 1997-09-18 | The Immune Response Corporation | Targeted delivery of genes encoding interferon |
EP0956301A2 (de) * | 1996-10-18 | 1999-11-17 | Valentis Inc. | Il-12 genexpressions- und transfersysteme und verwendungen |
US6034072A (en) * | 1997-02-10 | 2000-03-07 | Genemedicine, Inc. | IL-2 gene expression and delivery systems and uses |
-
1999
- 1999-03-12 CA CA002323604A patent/CA2323604A1/en not_active Abandoned
- 1999-03-12 JP JP2000536861A patent/JP2002506647A/ja active Pending
- 1999-03-12 EP EP99911340A patent/EP1064383A2/de not_active Withdrawn
- 1999-03-12 WO PCT/US1999/005394 patent/WO1999047678A2/en not_active Application Discontinuation
- 1999-03-12 AU AU30003/99A patent/AU3000399A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999047678A3 (en) | 1999-12-09 |
WO1999047678A9 (en) | 2000-11-09 |
AU3000399A (en) | 1999-10-11 |
JP2002506647A (ja) | 2002-03-05 |
EP1064383A2 (de) | 2001-01-03 |
WO1999047678A2 (en) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Toda et al. | In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity | |
Kramm et al. | Gene therapy for brain tumors | |
US6399588B1 (en) | Cancer treatment method utilizing plasmids suitable for IL-2 expression | |
US6051428A (en) | Rapid production of autologous tumor vaccines | |
US6034072A (en) | IL-2 gene expression and delivery systems and uses | |
CA2323604A1 (en) | Interferon alpha plasmids and delivery systems, and methods of making and using the same | |
AU675948B2 (en) | Bystander effect tumoricidal therapy | |
JPH10513362A (ja) | 生体活性な融合タンパク質および先在する腫瘍の治療 | |
Tamura et al. | Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer | |
WO1998034952A9 (en) | Il-2 gene expression and delivery systems and uses | |
KR102056066B1 (ko) | 세포외 기질 분해 인자를 발현하는 재조합 아데노바이러스를 포함하는 항암용 조성물 | |
Shi et al. | Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF | |
JP2003508016A (ja) | Cd40/cd40lキメラポリペプチドをコードする核酸、それらの生成方法及びそれらの使用 | |
Herrmann | Cancer gene therapy: principles, problems, and perspectives | |
KR20240013750A (ko) | Ras 돌연변이를 표적으로 하는 t 세포 수용체 및 그의 용도 | |
CA2337496A1 (en) | Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same | |
WO2000006759A9 (en) | Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same | |
Avalosse et al. | Gene therapy for cancer | |
Davidoff et al. | Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12 | |
US20220213160A1 (en) | Protein heterodimer and use thereof | |
Missol et al. | Introduction of murine Il-4 gene into B16 (F10) melanoma tumors by direct gene transfer with DNA-liposome complexes | |
CZ20003807A3 (cs) | DNA konstrukt, izolovaná molekula nukleové kyseliny, homologně rekombinantní buňka a její použití, způsob pozměnění exprese endogenního G-CSF genu a způsob produkce G-CSF | |
CN109748974B (zh) | 一种基因修饰的树突状细胞疫苗的制备及应用 | |
Paul et al. | Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12) | |
Eslahi et al. | Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |